File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells

TitleFHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells
Authors
Issue Date2011
Citation
Cancer Letters, 2011, v. 304 n. 2, p. 97-106 How to Cite?
AbstractFHL2 displays tumor promoting or tumor suppressing activities depending on the types of tumor cells. In this study, we demonstrated that FHL2 overexpression inhibits the proliferation of human HCC cells Hep3B through cell cycle regulation by decreasing cyclin D1 expression while increasing the expressions of p21 and p27. FHL2 overexpression also inhibits migration and invasion of Hep3B cells through the regulation of epithelial-mesenchymal transition. Surprisingly, we also demonstrated an antiapoptotic function for FHL2 overexpression with increased resistance to doxorubicin-induced apoptosis, which indicates the separation of anti-proliferative and anti-apoptotic role of FHL2. Taken together, our results indicate FHL2 could exert anti-apoptotic effect independent of tumor growth suppression. © 2011 Elsevier Ireland Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/194308
ISSN
2015 Impact Factor: 5.992
2015 SCImago Journal Rankings: 2.331
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorNg, C-F-
dc.contributor.authorNg, PKS-
dc.contributor.authorLui, VWY-
dc.contributor.authorLi, J-
dc.contributor.authorChan, JYW-
dc.contributor.authorFung, K-P-
dc.contributor.authorNg, Y-K-
dc.contributor.authorLai, PBS-
dc.contributor.authorTsui, SKW-
dc.date.accessioned2014-01-30T03:32:26Z-
dc.date.available2014-01-30T03:32:26Z-
dc.date.issued2011-
dc.identifier.citationCancer Letters, 2011, v. 304 n. 2, p. 97-106-
dc.identifier.issn0304-3835-
dc.identifier.urihttp://hdl.handle.net/10722/194308-
dc.description.abstractFHL2 displays tumor promoting or tumor suppressing activities depending on the types of tumor cells. In this study, we demonstrated that FHL2 overexpression inhibits the proliferation of human HCC cells Hep3B through cell cycle regulation by decreasing cyclin D1 expression while increasing the expressions of p21 and p27. FHL2 overexpression also inhibits migration and invasion of Hep3B cells through the regulation of epithelial-mesenchymal transition. Surprisingly, we also demonstrated an antiapoptotic function for FHL2 overexpression with increased resistance to doxorubicin-induced apoptosis, which indicates the separation of anti-proliferative and anti-apoptotic role of FHL2. Taken together, our results indicate FHL2 could exert anti-apoptotic effect independent of tumor growth suppression. © 2011 Elsevier Ireland Ltd.-
dc.languageeng-
dc.relation.ispartofCancer Letters-
dc.titleFHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.canlet.2011.02.001-
dc.identifier.pmid21377781-
dc.identifier.scopuseid_2-s2.0-79952735908-
dc.identifier.volume304-
dc.identifier.issue2-
dc.identifier.spage97-
dc.identifier.epage106-
dc.identifier.isiWOS:000289601400004-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats